Vertex Pharmaceuticals Incorporated

Peptide Based Infection Therapeutics Market Set to Deliver Major Revenue Shares during the Forecast Period

2019-08-14 // 0 Comments

According to Fact.MR’s research report on the global peptide based infection therapeutics market, the market is anticipated to show a robust growth rate during the forecasted [read full press release…]

Peptide Based Infection Therapeutics Market Projected to Experience Major Revenue Boost during the Period between 2017-2022

2019-02-25 // 0 Comments

Rockville , USA, 2019-Feb-25 — /EPR Network/ —Peptide therapeutics are stable, safe, tolerable, possess selective nature, and effective. They are used in the treatment of [read full press release…]

Global Peptide Based Infection Therapeutics Market Expected to Deliver Dynamic Progression until 2022

2019-01-11 // 0 Comments

There is a need to develop novel therapeutic agents in order to fight infections. Peptide therapeutics are used to fight infectious diseases. The global peptide [read full press release…]

Peptide Based Infection Therapeutics Market Expected to Reflect a Value US$ 1.5 Bn by 2022-end

2018-04-09 // 0 Comments

Dublin 2, Ireland, 2018-Apr-09 — /EPR Network/ — The global market discussion on peptide based infection therapeutics industry can be found in the latest study by Fact.MR, [read full press release…]